All lobbying filings

MAYER BROWN LLP

MAYER BROWN LLP filed a registration for NOVOCURE on January 21, 2026.

Lobbying for NOVOCURE · Medical technology company.

All filings by MAYER BROWN LLP · Everything NOVOCURE has reported

Filing · LD-1 registration Registration

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 21, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Pennsylvania

Official filing document

Lobbyists on this filing 2

DANIEL HARDER New on this filing

Previously held: Staff Assistant/Clerk - House Ways and Means 2014; Legislative Director - Rep. Mike Bishop 2015-2018
WARREN PAYNE New on this filing

Previously held: U.S. Intl Comm: Trade Analyst, 2002-04; Economic Advisor, 2004-07; House Ways and Means Committee; Trade Economist, 2007-09; Sr. Economist//Trade Advisor, 2009-11; Chief Economist, 2011-13; Policy Director, 2012-15

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

General issues pertaining to Section 301 investigations.

Tariff (miscellaneous tariff bills)

General issues pertaining to Section 301 investigations.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

NOVOCURE

Switzerland · Baar · owns 100% of the client · contributed $0

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.